株探米国株
日本語 英語
エドガーで原本を確認する
0001443669FALSE00014436692026-02-062026-02-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 6, 2026
Proto Labs, Inc.
(Exact name of registrant as specified in its charter)
Minnesota 001-35435 41-1939628
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer
Identification Number)
5540 Pioneer Creek Drive
Maple Plain, Minnesota
55359
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:
(763) 479-3680
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share PRLB New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 2.02. Results of Operations and Financial Condition.
On February 6, 2026, Proto Labs, Inc. issued a press release announcing its fourth quarter and full year 2025 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
99.1
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Proto Labs, Inc.
Date:
February 6, 2026
By: /s/ Daniel Schumacher
Daniel Schumacher
Chief Financial Officer

EX-99.1 2 prlb-202626xexx991.htm EX-99.1 Document

Exhibit 99.1
logoa.jpg
logo1a.jpg
Protolabs Reports Financial Results for the Fourth Quarter and Full Year 2025
Record Quarterly Revenue of $136.5 Million, a 12.1% Increase Year-Over-Year

Record Annual Revenue of $533.1 Million, a 6.4% Increase Year-Over-Year
MINNEAPOLIS – February 6, 2026 – Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the fourth quarter and full year ended December 31, 2025.

"Protolabs closed 2025 with strong momentum, delivering accelerated growth, record revenue, and solid earnings in the fourth quarter," said President and Chief Executive Officer Suresh Krishna. "2026 is a pivotal year of transformation and acceleration as we establish the foundation to execute our long-term strategic pillars: elevating the customer experience, accelerating innovation, expanding production, and driving operational efficiency. We believe the organizational and operational changes underway position Protolabs for faster growth and improved profitability over time. I'm confident in our ability to execute with speed, discipline, and innovation as we deliver long-term value for customers and shareholders."

Fourth Quarter 2025 Financial Highlights:
•Revenue was a record $136.5 million, a 12.1% increase over the fourth quarter of 2024.
◦CNC Machining revenue grew 25.0% year-over-year.
◦Revenue per customer contact increased 23.2% year-over-year.
•Net income was $6.0 million, or $0.25 per diluted share, compared to a net loss of $(0.4) million, or $(0.02) per diluted share, in the fourth quarter of 2024.
•Non-GAAP net income was $10.7 million, or $0.44 per diluted share, compared to $9.4 million, or $0.38 per diluted share, in the fourth quarter of 2024. See “Non-GAAP Financial Measures” below.

Full Year 2025 Financial Highlights:
•Revenue was a record $533.1 million, a 6.4% increase over 2024.
◦CNC Machining revenue grew 17.6% year-over-year.
◦Revenue per customer contact increased 13.3% year-over-year.
•Revenue growth by fulfillment:
◦Factory: $416.9 million, a 4.1% increase year-over-year.
◦Network: $116.2 million, a 15.7% increase year-over-year.
•Net income was $21.2 million, or $0.88 per diluted share, compared to net income of $16.6 million, or $0.66 per diluted share, in 2024.
•Non-GAAP net income was $40.2 million, or $1.66 per diluted share, compared to $41.2 million, or $1.63 per diluted share, in 2024. See “Non-GAAP Financial Measures” below.
•Adjusted EBITDA was $78.1 million, or 14.7% of revenue. See “Non-GAAP Financial Measures” below.
•Cash generated from operations was $74.5 million in 2025.
•Cash and investments balance was $142.4 million as of December 31, 2025.

Dan Schumacher, Chief Financial Officer, added: "We delivered solid results in 2025 with record revenue and strong cash flow. As we move through 2026, we are implementing targeted changes to improve efficiency and build a more scalable operating model.



These actions will support continued revenue growth and create a stronger foundation for long‑term financial performance."

Long-Term Strategic Pillars:

To support Protolabs' long-term strategy, we have aligned the organization around four strategic pillars:

•Elevate Customer Experience: remove friction across the customer journey to deliver a best-in-class experience and increase revenue per customer. Enable employees to serve customers more efficiently, driving faster growth.
•Accelerate Innovation: reaccelerate innovation across core manufacturing services to drive outsized growth and an accelerated pace of new releases. Leverage differentiated IP and deep manufacturing and engineering talent.
•Expand Production: take a deliberate, customer-led approach—prioritizing the right customers, applications, and capabilities. Begin with most strategic customers and scale over time.
•Drive Operational Efficiency: expand Factory and Network gross margins and capture operating expense leverage via efficiencies and productivity. Reallocate resources to fund highest-priority growth initiatives.

Financial Guidance and Outlook:

•In fiscal year 2026, Protolabs expects to generate revenue growth between 6% and 8%.
•In the first quarter of 2026, the Company expects to generate revenue between $130.0 million and $138.0 million.
•In the first quarter of 2026, the Company expects diluted net income per share between $0.17 and $0.25, and non-GAAP diluted net income per share between $0.36 and $0.44. See "Non-GAAP Financial Measures" below.

Non-GAAP Financial Measures
The Company has included non-GAAP revenue growth by region and by service line that excludes the impact of changes in foreign currency exchange rates (collectively, “non-GAAP revenue growth”). Management believes these metrics, when viewed in conjunction with the comparable GAAP metrics, are useful in evaluating the underlying business trends and ongoing operating performance of the Company.
The Company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, CEO transition costs, restructuring and transformation costs, and costs related to exit and disposal activities (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the Company’s financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency, CEO transition costs, restructuring and transformation costs, and costs related to exit and disposal activities (collectively, “Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense and amortization expense, in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, CEO transition costs, restructuring and transformation costs, and costs related to exit and disposal activities (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP net income and non-GAAP net income per share, in each case, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs, restructuring and transformation costs, and costs related to exit and disposal activities (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has provided below reconciliations of GAAP to non-GAAP net income (loss), non-GAAP net income (loss) per share, non-GAAP gross margin, non-GAAP operating margin, non-GAAP revenue growth by region and by service line, and Adjusted EBITDA and Adjusted EBITDA margin, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company’s management and board of directors to understand and evaluate operating performance and trends, provide useful measures for period-to-period comparisons of the Company’s business, and in determining executive and senior management incentive compensation.



Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. These non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in our condensed consolidated financial statements and are subject to inherent limitations. Investors should review the reconciliations of non-GAAP financial measures to the comparable GAAP financial measures that are included in this press release.
Conference Call
The Company has scheduled a conference call to discuss its fourth quarter and full year 2025 financial results and outlook for 2026 today, February 6, 2026 at 8:30 a.m. EST. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EST start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/cbdwr5wf/. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.
About Protolabs
Protolabs is the world’s fastest manufacturing service enabling companies across every industry to streamline production of quality parts throughout the entire product life cycle. From custom prototyping to end-use production, we support product developers, engineers, and supply chain teams along every phase of their manufacturing journey. Get started now at protolabs.com.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
Source: Proto Labs, Inc.

Investor Relations Contacts
Protolabs
Ryan Johnsrud, 612-225-4873
Manager – Investor Relations and Corporate Development
ryan.johnsrud@protolabs.com

Gateway Group, Inc.
949-574-3860
PRLB@gateway-grp.com
Media Contact
Protolabs
Brent Renneke, 763-479-7704
Corporate Communications Manager
brent.renneke@protolabs.com



Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
December 31,
2025
December 31,
2024
(Unaudited)
Assets
Current assets
Cash and cash equivalents $ 110,826  $ 89,071 
Short-term marketable securities 17,297  14,019 
Accounts receivable, net 78,962  66,504 
Inventory 14,401  12,305 
Income taxes receivable 2,465  2,906 
Prepaid expenses and other current assets 9,590  10,049 
Total current assets 233,541  194,854 
Property and equipment, net 212,201  227,263 
Goodwill 273,991  273,991 
Other intangible assets, net 18,612  21,422 
Long-term marketable securities 14,308  17,773 
Operating lease assets 2,836  2,993 
Finance lease assets 424  692 
Other long-term assets 4,442  4,524 
Total assets $ 760,355  $ 743,512 
Liabilities and shareholders' equity    
Current liabilities    
Accounts payable $ 15,104  $ 15,504 
Accrued compensation 23,674  16,550 
Accrued liabilities and other 26,783  19,621 
Current operating lease liabilities 1,155  1,287 
Current finance lease liabilities 286  309 
Total current liabilities 67,002  53,271 
Long-term operating lease liabilities 1,606  1,633 
Long-term finance lease liabilities —  287 
Long-term deferred tax liabilities 16,598  13,565 
Other long-term liabilities 4,277  4,605 
Shareholders' equity 670,872  670,151 
Total liabilities and shareholders' equity $ 760,355  $ 743,512 



Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2025 2024 2025 2024
Revenue
Injection Molding $ 47,613  $ 45,641  $ 191,521  $ 194,215 
CNC Machining 65,496  52,389  243,327  206,887 
3D Printing 18,807  19,467  80,298  83,767 
Sheet Metal 4,384  4,047  17,160  15,265 
Other Revenue 193  206  821  756 
Total Revenue 136,493  121,750  533,127  500,890 
Cost of revenue 76,121  69,793  295,990  277,690 
Gross profit 60,372  51,957  237,137  223,200 
Operating expenses
Marketing and sales 25,261  23,003  98,315  92,073 
Research and development 10,321  9,698  42,808  41,298 
General and administrative 17,050  15,166  69,813  64,333 
Restructuring and transformation costs 749  —  749  — 
Costs related to exit and disposal activities 191  5,585  342  5,585 
Total operating expenses 53,572  53,452  212,027  203,289 
Income (loss) from operations 6,800  (1,495) 25,110  19,911 
Other income, net 1,352  1,213  5,952  4,761 
Income (loss) before income taxes 8,152  (282) 31,062  24,672 
Provision for income taxes 2,153  122  9,821  8,079 
Net income (loss) $ 5,999  $ (404) $ 21,241  $ 16,593 
Net income (loss) per share:
Basic $ 0.25  $ (0.02) $ 0.89  $ 0.66 
Diluted $ 0.25  $ (0.02) $ 0.88  $ 0.66 
Shares used to compute net income (loss) per share:
Basic 23,760,364 24,474,051 23,922,703 25,096,117
Diluted 24,168,052 24,474,051 24,245,199 25,212,178



Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Twelve Months Ended
December 31,
2025 2024
Operating activities
Net income $ 21,241  $ 16,593 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 33,814  35,808 
Stock-based compensation expense 15,729  16,999 
Deferred taxes 2,912  (5,153)
Interest on finance lease obligations 20  33 
Loss on impairment of equipment —  256 
Impairments related to exit and closure of facilities 448  2,333 
Gain on disposal of property and equipment (4) (13)
Other (223)
Changes in operating assets and liabilities 567  10,972 
Net cash provided by operating activities 74,504  77,829 
Investing activities
Purchases of property, equipment and other capital assets (14,842) (9,169)
Proceeds from sales of property, equipment and other capital assets 834  34 
Purchases of marketable securities (17,015) (25,070)
Proceeds from call redemptions and maturities of marketable securities 17,613  19,209 
Net cash used in investing activities (13,410) (13,580)
Financing activities
Proceeds from issuance of common stock from equity plans 6,340  4,019 
Purchases of shares withheld for tax obligations (3,434) (1,995)
Repurchases of common stock (42,963) (60,278)
Principal repayments of finance lease obligations (309) (296)
Net cash used in financing activities (40,366) (58,550)
Effect of exchange rate changes on cash and cash equivalents 1,027  (418)
Net increase in cash and cash equivalents 21,755  5,281 
Cash and cash equivalents, beginning of period 89,071  83,790 
Cash and cash equivalents, end of period $ 110,826  $ 89,071 



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income (Loss) and Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2025 2024 2025 2024
Non-GAAP net income (loss), adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs, restructuring and transformation costs and costs related to exit and disposal activities
GAAP net income (loss) $ 5,999  $ (404) $ 21,241  $ 16,593 
Add back:
Stock-based compensation expense 3,801  4,283  15,729  16,999 
Amortization expense 933  911  3,703  3,707 
Unrealized loss (gain) on foreign currency 186  (324) (130) (1)
CEO transition costs —  —  1,376  — 
Restructuring and transformation costs 749  —  749  — 
Costs related to exit and disposal activities 191  5,585  342  5,585 
Total adjustments 1
5,860  10,455  21,769  26,290 
Income tax benefits on adjustments 2
(1,110) (649) (2,810) (1,715)
Non-GAAP net income $ 10,749  $ 9,402  $ 40,200  $ 41,168 
Non-GAAP net income per share:
Basic $ 0.45  $ 0.38  $ 1.68  $ 1.64 
Diluted $ 0.44  $ 0.38  $ 1.66  $ 1.63 
Shares used to compute non-GAAP net income per share:
Basic 23,760,364 24,474,051 23,922,703 25,096,117
Diluted 24,168,052 24,689,181 24,245,199 25,212,178
1Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency, CEO transition costs, restructuring and transformation costs and costs related to exit and disposal activities were included in the following GAAP consolidated statement of operations categories:
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2025 2024 2025 2024
Cost of revenue $ 812  $ 876  $ 3,162  $ 3,304 
Marketing and sales 894  734  3,317  3,112 
Research and development 702  690  2,826  2,721 
General and administrative 2,326  2,894  11,503  11,569 
Restructuring and transformation costs 749  —  749  — 
Costs related to exit and disposal activities 191  5,585  342  5,585 
Total operating expenses 4,862  9,903  18,737  22,987 
Other income, net 186  (324) (130) (1)
Total adjustments $ 5,860  $ 10,455  $ 21,769  $ 26,290 
2For the three and twelve months ended December 31, 2025 and 2024, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the respective period.



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Gross Margin
(In thousands)
(Unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2025 2024 2025 2024
Revenue $ 136,493  $ 121,750  $ 533,127  $ 500,890 
Gross profit 60,372  51,957  237,137  223,200 
GAAP gross margin 44.2 % 42.7 % 44.5 % 44.6 %
Add back:    
Stock-based compensation expense 469  534  1,792  1,935 
Amortization expense 343  342  1,370  1,369 
Total adjustments 812  876  3,162  3,304 
Non-GAAP gross profit $ 61,184  $ 52,833  $ 240,299  $ 226,504 
Non-GAAP gross margin 44.8 % 43.4 % 45.1 % 45.2 %



Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2025 2024 2025 2024
Revenue $ 136,493  $ 121,750  $ 533,127  $ 500,890 
Income (loss) from operations 6,800  (1,495) 25,110  19,911 
GAAP operating margin 5.0 % (1.2 %) 4.7 % 4.0 %
Add back:
Stock-based compensation expense 3,801  4,283  15,729  16,999 
Amortization expense 933  911  3,703  3,707 
CEO transition costs —  —  1,376  — 
Restructuring and transformation costs 749  —  749  — 
Costs related to exit and disposal activities 191  5,585  342  5,585 
Total adjustments 5,674  10,779  21,899  26,291 
Non-GAAP income from operations $ 12,474  $ 9,284  $ 47,009  $ 46,202 
Non-GAAP operating margin 9.1 % 7.6 % 8.8 % 9.2 %



Proto Labs, Inc.
Reconciliation of GAAP Net Income (Loss) to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2025 2024 2025 2024
Revenue $ 136,493  $ 121,750  $ 533,127  $ 500,890 
GAAP net income (loss) 5,999  (404) 21,241  16,593 
GAAP net income (loss) margin 4.4 % (0.3 %) 4.0 % 3.3 %
Add back:
Amortization expense $ 933  $ 911  $ 3,703  $ 3,707 
Depreciation expense 7,188  7,913  30,111  32,101 
Interest income, net (1,261) (1,225) (4,793) (4,749)
Provision for income taxes 2,153  122  9,821  8,079 
EBITDA 15,012  7,317  60,083  55,731 
EBITDA Margin 11.0 % 6.0 % 11.3 % 11.1 %
Add back:
Stock-based compensation expense 3,801  4,283  15,729  16,999 
Unrealized loss (gain) on foreign currency 186  (324) (130) (1)
CEO transition costs —  —  1,376  — 
Restructuring and transformation costs 749  —  749  — 
Costs related to exit and disposal activities 191  5,585  342  5,585 
Total adjustments 4,927  9,544  18,066  22,583 
Adjusted EBITDA $ 19,939  $ 16,861  $ 78,149  $ 78,314 
Adjusted EBITDA Margin 14.6 % 13.8 % 14.7 % 15.6 %



Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Region
(In thousands)
(Unaudited)
Three Months Ended
December 31, 2025
Three Months Ended
December 31, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
United States $ 111,986  $ —  $ 111,986  $ 96,599  15.9 % 15.9 %
Europe 24,507  (1,398) 23,109  25,151  (2.6) (8.1)
Total revenue $ 136,493  $ (1,398) $ 135,095  $ 121,750  12.1 % 11.0 %
Twelve Months Ended
December 31, 2025
Twelve Months Ended
December 31, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
United States $ 432,326  $ —  $ 432,326  $ 396,192  9.1 % 9.1 %
Europe 100,801  (3,453) 97,348  104,698  (3.7 %) (7.0 %)
Total revenue $ 533,127  $ (3,453) $ 529,674  $ 500,890  6.4 % 5.7 %

1Revenue for the three and twelve months ended December 31, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and twelve months ended December 31, 2024 to GAAP revenue for the three and twelve months ended December 31, 2025.
3This column presents the percentage change from GAAP revenue for the three and twelve months ended December 31, 2024 to non-GAAP revenue for the three and twelve months ended December 31, 2025 (as recalculated using the foreign currency exchange rates in effect during the three and twelve months ended December 31, 2024) in order to provide a constant-currency comparison.



Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Service Line
(In thousands)
(Unaudited)
Three Months Ended
December 31, 2025
Three Months Ended
December 31, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
Injection Molding $ 47,613  $ (333) $ 47,280  $ 45,641  4.3 % 3.6 %
CNC Machining 65,496  (857) 64,639  52,389  25.0  23.4 
3D Printing 18,807  (171) 18,636  19,467  (3.4) (4.3)
Sheet Metal 4,384  (34) 4,350  4,047  8.3  7.5 
Other Revenue 193  (3) 190  206  (6.3) (7.8)
Total revenue $ 136,493  $ (1,398) $ 135,095  $ 121,750  12.1 % 11.0 %
Twelve Months Ended
December 31, 2025
Twelve Months Ended
December 31, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAP GAAP
Revenues
Injection Molding $ 191,521  $ (1,039) $ 190,482  $ 194,215  (1.4 %) (1.9 %)
CNC Machining 243,327  (1,838) 241,489  206,887  17.6  16.7 
3D Printing 80,298  (507) 79,791  83,767  (4.1) (4.7)
Sheet Metal 17,160  (64) 17,096  15,265  12.4  12.0 
Other Revenue 821  (5) 816  756  8.6  7.9 
Total revenue $ 533,127  $ (3,453) $ 529,674  $ 500,890  6.4 % 5.7 %

1Revenue for the three and twelve months ended December 31, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three and twelve months ended December 31, 2024 to GAAP revenue for the three and twelve months ended December 31, 2025.
3This column presents the percentage change from GAAP revenue for the three and twelve months ended December 31, 2024 to non-GAAP revenue for the three and twelve months ended December 31, 2025 (as recalculated using the foreign currency exchange rates in effect during the three and twelve months ended December 31, 2024) in order to provide a constant-currency comparison.



Proto Labs, Inc.
Customer Contact Information
(In thousands, except customer contacts and per customer contact amounts)
(Unaudited)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2025 2024 2025 2024
Revenue $ 136,493  $ 121,750  $ 533,127  $ 500,890 
Customer contacts 19,621 21,558 48,415 51,552
Revenue per customer contact1
$ 6,956  $ 5,648  $ 11,012  $ 9,716 

1Revenue per customer contact is calculated using the revenue recognized during the respective period divided by the actual number of customer contacts served during the same period. Customer contacts are product developers, engineers, procurement and supply chain professionals and other individuals who place an order, and that order is shipped and invoiced during the period. The Company believes revenue per customer contact is useful to investors in evaluating the underlying business trends and ongoing operating performance of the Company.
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Guidance
(Unaudited)

Q1 2026 Outlook
Low High
GAAP diluted net income per share $ 0.18  $ 0.26 
Add back:
Stock-based compensation expense 0.12  0.12 
Amortization expense 0.03  0.03 
Restructuring and transformation costs 0.02  0.02 
Unrealized (gain) loss on foreign currency 0.00  0.00 
Total adjustments 0.18  0.18 
Non-GAAP diluted net income per share $ 0.36  $ 0.44